Medical News

RSS

LTC Financial Partners goes green

If you're in the market for long term care insurance but hate to fill out applications and wait, wait, wait, a leading agency has an alternative for you. Dispense with the paper and the delay; complete an electronic application, with live hand-holding, and get an answer pronto. The agency is LTC Financial Partners LLC (LTCFP), one of the nation's most experienced long term care insurance agencies.

28 Jul 2010

Dutchess Private Equities' Convertible Debenture and Senior Note converted into equity for UDHI

Union Dental Holdings, Inc. - http://www.uniondental.com - a provider of multi-state dental services for union members, is pleased to announce Dutchess Private Equities has converted both its Convertible Debenture and Senior Note which together total $659,000 into equity in the Company. The original amount of the note was $1,400,000 and has been reduced over the years.

28 Jul 2010

Bruker second-quarter adjusted EPS grows 114% y-o-y to $0.15

Bruker Corporation today reported financial results for the three and six months ended June 30, 2010.

28 Jul 2010

Clinical Pharmacokinetics Research Laboratory deploys AB SCIEX mass spectrometry technology

AB SCIEX, a global leader in life science analytical technologies, today announced that the Clinical Pharmacokinetics Research Laboratory at the University of Rhode Island's College of Pharmacy is using AB SCIEX mass spectrometry technology to develop a novel test that would enable clinical researchers to use saliva to monitor immunosuppressant drugs commonly administered to make organ transplants successful.

28 Jul 2010

Mastech second-quarter revenues decrease to $16.9 million

Mastech Holdings, Inc., a national provider of Information Technology and Specialized Healthcare staffing services, announced today its financial results for the second quarter ended June 30, 2010.

28 Jul 2010

Cipher Pharmaceuticals second-quarter net revenues increase to $2.2 million

Cipher Pharmaceuticals Inc. today announced its financial and operational results for the three and six months ended June 30, 2010.

28 Jul 2010

FDA approves Tris Pharma's first-time generic of Methylphenidate Hydrochloride Oral Solution

Tris Pharma, a specialty pharmaceutical company that develops innovative drug delivery technologies, announced that the US Food and Drug Administration (FDA) has approved a first-time generic of Methylphenidate Hydrochloride Oral Solution equivalent to brand name Methylin® Oral Solution marketed by Shionogi Pharmaceuticals, Inc.

28 Jul 2010

Redpoint Bio issued patent that covers high-throughput screening technology

Redpoint Bio Corporation, a company focused on the development of healthier foods and beverages and new approaches to the treatment of diabetes and obesity, today announced the issuance of Patent No. 7,749,730 B2 by the U.S. Patent and Trademark Office entitled "High Throughput Screening Assay for the TRPm5 Ion Channel."

28 Jul 2010

United Therapeutics second-quarter total revenues increase to $137.5 million

United Therapeutics Corporation today announced its results of operations for the quarter ended June 30, 2010.

28 Jul 2010

Exact Sciences reports total revenues of $1.3M for second-quarter 2010

Exact Sciences Corp. today announced its financial results for the second quarter ended June 30, 2010.

28 Jul 2010

Researchers establish new criteria for liver transplantation

Researchers at the University of California, San Francisco propose that treatments used on liver cancers beyond the established Milan criteria for liver transplantation may be appropriate for all patients with hepatocellular carcinoma who are listed for transplantation. Full details appear in the August issue of Liver Transplantation, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases.

28 Jul 2010

Dyax second-quarter total revenues increase to $15.1 million

Dyax Corp. today announced financial results for the second quarter ended June 30, 2010.

28 Jul 2010

Corning second-quarter 2010 sales up 10%

Corning Incorporated today announced its results for the second quarter 2010.

28 Jul 2010

CVS Caremark second-quarter net revenues decrease $864 million to $24.0 billion

CVS Caremark Corporation, today announced revenues, operating profit, and net income for the three and six months ended June 30, 2010.

28 Jul 2010

Allos reports topline results from Phase 2b trial of FOLOTYN vs erlotinib in advanced NSCLC

Allos Therapeutics, Inc. today announced topline results from the Company's randomized Phase 2b investigational trial of FOLOTYN® (pralatrexate injection) versus erlotinib in patients with Stage IIIB/IV (advanced) non-small cell lung cancer (NSCLC) who had received one or two prior systemic treatments including at least one prior platinum-based regimen. The objective of the trial was to estimate the efficacy of FOLOTYN compared to that of erlotinib as assessed by overall survival.

28 Jul 2010

Morinda Holdings chosen as one of the Healthiest Companies in America

Amid the glaring spotlight on healthcare reform in the US, Interactive Health Solutions published their list of the "Healthiest Companies in America" for 2010. The list is a group of 34 companies that have significantly reduced healthcare costs through employee participation in a prevention-based health program in the workplace. Morinda Holdings, Inc. (parent company of Tahitian Noni International) was chosen from over 1,300 corporations in the United Sates ranging in size from as little as 100 to over 50,000 employees, as one of the "Healthiest Companies in America."

28 Jul 2010

ViroPharma second-quarter net sales increase 33% to $109.0 million

ViroPharma Incorporated reported today its financial results for the second quarter ended June 30, 2010.

28 Jul 2010

Viking Systems extends supply contract with Boston Scientific

Viking Systems, Inc. announced today an extension of its supply contract with Boston Scientific. Based on the continued success of Boston Scientific's SpyGlass Direct Visualization System, the companies agreed to extend the term of the supply agreement through May 2012.

28 Jul 2010

Waters second-quarter 2010 sales increase 8% to $391 million

Waters Corporation reported today second quarter 2010 sales of $391 million, an increase of 8% over sales of $363 million in the second quarter of 2009. These quarterly sales include an adverse foreign currency translation impact of approximately 1%. On a GAAP basis, earnings per diluted share for the second quarter were $0.90, compared to $0.72 for the second quarter in 2009.

28 Jul 2010